
CAS 2484719-15-3
:Pyridine, 3-[3-(1-methylethoxy)androsta-5,16-dien-17-yl]-
Description:
Pyridine, 3-[3-(1-methylethoxy)androsta-5,16-dien-17-yl]- is a chemical compound characterized by its complex structure, which includes a pyridine ring and a steroid backbone derived from androstane. The presence of the pyridine moiety contributes to its potential as a heterocyclic compound, often influencing its reactivity and solubility properties. The compound features a 1-methylethoxy group, which can enhance lipophilicity and affect biological activity. Typically, compounds of this nature may exhibit various pharmacological properties, making them of interest in medicinal chemistry. The specific arrangement of functional groups and stereochemistry can significantly impact the compound's interactions with biological targets. Additionally, the presence of multiple rings and substituents suggests potential for diverse chemical reactivity, including electrophilic and nucleophilic interactions. Overall, this compound exemplifies the intricate relationship between structure and function in organic chemistry, particularly in the context of drug design and development.
Formula:C27H37NO
Synonyms:- Abiraterone Isopropyl Ether
- Abiraterone impurities426
- Abiraterone Impurity 08
- Pyridine, 3-[3-(1-methylethoxy)androsta-5,16-dien-17-yl]-
- Abiraterone Isopropyl EtherQ: What is
- Abiraterone Isopropyl Ether Q: What is the CAS Number of
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Abiraterone Isopropyl Ether (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3β-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C27H37NOColor and Shape:Pale Yellow SolidMolecular weight:391.28751Abiraterone Isopropyl Ether
CAS:Formula:C27H37NOColor and Shape:Pale Yellow SolidMolecular weight:391.60Abiraterone Isopropyl Ether
CAS:Controlled Product<p>Applications Abiraterone Isopropyl Ether is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.<br>References Denis, L., et al.: Cancer, 72, 3888 (1993); Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995); Denmeade, S., et al.: Nat. Rev., 2, 389(2002); Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005)<br></p>Formula:C27H37NOColor and Shape:NeatMolecular weight:391.59Iso propyl ether aberaterone
CAS:Controlled ProductIso propyl ether abiraterone is a medicinal compound that has shown promising results in the treatment of cancer. It is an inhibitor of CYP17A1, which is a protein involved in the production of androgens such as testosterone. By inhibiting this protein, iso propyl ether abiraterone can reduce the levels of androgens in the body, which can slow or stop the growth of certain types of cancer cells. This compound has been shown to induce apoptosis (cell death) in cancer cells and has demonstrated anticancer activity in both human and Chinese hamster ovary cell lines. Iso propyl ether abiraterone is an analog of other kinase inhibitors and has potential for use in combination with other anticancer drugs.Formula:C27H37NOPurity:Min. 95%Molecular weight:391.6 g/mol





